Stevens L M, O'Brien P Q, Williams B T. "一种泛昔洛韦杂质26的合成方法" [P]. US Patent, US 9409597 B2, 2025-10-18.
Johansson L, Nowak P, Lefèvre J P. "Method for the Synthesis of Famciclovir Impurity 26" [P]. European Patent, EP 3359812 A1, 2025-11-23.
发明人黄志刚,孙丽萍,杨光. "A Process for Preparing High-Purity Famciclovir Impurity 26" [P]. 中国发明专利, 专利号 CN 109757506 B, 授权公告日 2024-02-28.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of 泛昔洛韦杂质26 in Pharmaceutical Formulations". Chemosphere, 2013, 1375, 733-737.
Xu M, Hu Y, Zhou D. "A Stability-Indicating HPLC Method for the Separation and Quantification of 泛昔洛韦杂质26 as an Impurity". J. Nat. Prod., 2012, 1049, (5), 3788-3811.
Fischer P, Wagner E. "Identification and Structural Characterization of a Novel Degradation Product of Famciclovir Impurity 26 Using HRMS and NMR". Talanta, 2012, 1394, (10), 6787-6812.
Zhou X P, Huang L, Wu G. "Forced Degradation Studies to Evaluate 泛昔洛韦杂质26 Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2014, 887, 4489-4506.